CAR-T cells targeting EpCAM, which is upregulated in ovarian cancer, CRC, and peritoneal carcinomatosis, have shown remarkable success in eliminating EpCAM-expressing cancer cells [279,280]. This evidence concerns the gene EPCAM and ovarian cancer.